Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Fennec Pharmaceuticals Inc

FENC
Current price
6.84 USD +0.29 USD (+4.43%)
Last closed 8.66 CAD
ISIN CA31447P1009
Sector Healthcare
Industry Biotechnology
Exchange TO
Capitalization 238 613 384 CAD
Yield for 12 month -0.11 %
1Y
3Y
5Y
10Y
15Y
FENC
21.11.2021 - 28.11.2021

Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina. Address: 68 TW Alexander Drive, Research Triangle Park, NC, United States, 27709

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

130.72 CAD

P/E ratio

Dividend Yield

Current Year

+66 412 963 CAD

Last Year

+29 690 107 CAD

Current Quarter

+11 071 621 CAD

Last Quarter

+9 743 027 CAD

Current Year

+61 964 756 CAD

Last Year

+27 931 221 CAD

Current Quarter

+10 136 995 CAD

Last Quarter

+7 847 230 CAD

Key Figures FENC

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 3 594 717 CAD
Operating Margin TTM -9.23 %
Price to Earnings
Return On Assets TTM -12.96 %
PEG Ratio
Return On Equity TTM -1 005.59 %
Wall Street Target Price 130.72 CAD
Revenue TTM 30 866 641 CAD
Book Value -0.21 CAD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -65.50 %
Dividend Yield
Gross Profit TTM 27 864 053 CAD
Earnings per share -0.030 CAD
Diluted Eps TTM -0.030 CAD
Most Recent Quarter IV 2024
Quarterly Earnings Growth YOY
Profit Margin -46.71 %

Dividend Analytics FENC

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Dividend History FENC

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
Dividend CAGR 3Y
Dividend CAGR 5Y
Dividend CAGR 10Y
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
Forward Annual Dividend – CAD
Last Split Factor 1:3
Payout Ratio TTM
Last Split Date 05.09.2014

Stock Valuation FENC

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 11.95
Enterprise Value Revenue 3.45
Price Sales TTM 7.73
Enterprise Value EBITDA 34.22
Price Book MRQ 57.98

Financials FENC

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators FENC

For 52 weeks

5.64 CAD 10.13 CAD
50 Day MA 8.37 CAD
Shares Short Prior Month 23 694
200 Day MA 7.96 CAD
Short Ratio 173.29
Shares Short 23 394
Short Percent 0.12 %